John L. Lamattina

Insider Reports History

Location
81 Wyman St, Post Office Box 9046, Waltham, MA
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: John L. LaMattina
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John L. Lamattina:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LIGAND PHARMACEUTICALS INC Director Common Stock 30.7K $3.35M $109.15 Jun 6, 2025 Direct
Immunome Inc. Director Common Stock 67K $396K $5.91 Jan 15, 2023 Direct
Immunome Inc. Director Stock Option (Right to Buy) 6.5K Jun 8, 2023 Direct
LIGAND PHARMACEUTICALS INC Director Non-Qualified Stock Option (right to buy) 5.78K Jun 6, 2025 Direct
LIGAND PHARMACEUTICALS INC Director Non-Qualified Stock Option (right to buy) 5.44K Jun 14, 2024 Direct

Insider Reports Filed by John L. Lamattina

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LGND LIGAND PHARMACEUTICALS INC Jun 6, 2025 2 $0 4 Jun 10, 2025 Director
LGND LIGAND PHARMACEUTICALS INC Nov 27, 2024 3 -$172K 4 Dec 2, 2024 Director
LGND LIGAND PHARMACEUTICALS INC Jun 14, 2024 2 $0 4 Jun 18, 2024 Director
LGND LIGAND PHARMACEUTICALS INC Jun 9, 2023 2 $0 4 Jun 13, 2023 Director
IMNM Immunome Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
IMNM Immunome Inc. Jan 15, 2023 1 $60.5K 4 Jan 17, 2023 Director
LGND LIGAND PHARMACEUTICALS INC Dec 22, 2022 1 $0 4 Dec 27, 2022 Director
IMNM Immunome Inc. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
LGND LIGAND PHARMACEUTICALS INC Jun 10, 2022 2 $0 4 Jun 13, 2022 Director
LGND LIGAND PHARMACEUTICALS INC Nov 16, 2021 3 -$626K 4 Nov 17, 2021 Director
LGND LIGAND PHARMACEUTICALS INC Jun 4, 2021 2 $0 4 Jun 7, 2021 Director
IMNM Immunome Inc. May 28, 2021 1 $0 4 Jun 1, 2021 Director
IMNM Immunome Inc. May 24, 2021 2 $101K 4 May 26, 2021 Director